Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...

Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...